Home » Topics » BioWorld Science

BioWorld Science
RSS

Washington University extends research of Hoth's HT-ALZ in mouse model of Alzheimer's disease

June 10, 2022

New in vitro data support advancing SLS-004 for dementia with Lewy bodies

June 10, 2022

Adropin as novel therapeutic target to attenuate fibroblast activation and fibrosis in SSc

June 10, 2022

Exscientia describes MALT1 inhibitors

June 10, 2022

Lundbeck divulges catecholamine prodrugs for Parkinson's disease

June 10, 2022

New SERD inducers disclosed for treatment of cancer

June 10, 2022

Gilead Sciences describes GLP-1 receptor agonists

June 10, 2022

Enanta Pharmaceuticals patents Mpro inhibitors for coronovirus infections

June 10, 2022

For mutations, "synonymous" is not a synonym for silent, study finds

June 9, 2022

FDA clears IND application for SBT-115301 for autoimmune disease

June 9, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...